References
Larsen, K.B. Ann. Anat. 109, 421–427 (2008).
Bahado-Singh, R.O. et al. Am. J. Obstet. Gynecol. 167, 1009–14 (1992).
Reeves, R.H. et al. Nat. Genet. 11, 177–184 (1995).
Gardiner, K.J. Drug Des. Devel. Ther. 9, 103–125 (2015).
Belichenko, P.V. et al. Comp. Neurol. 480, 281–298 (2004).
Bartesaghi, R. et al. J. Neurosci. 35, 13843–13852 (2015).
Guidi, S. et al. Brain 137, 380–401 (2014).
Malberg, J.E., Eisch, A.J., Nestler, E.J. & Duman, R.S. J. Neurosci. 20, 9104–9110 (2000).
Reefhuis, J., Devine, O., Friedman, J.M., Louik, C. & Honein, M.A. B.M.J. 351, h3190 (2015).
Bianchi, D. Nat. Med. 18, 1041–1051 (2012).
Moon, J. et al. Behav. Neurosci. 124, 346–361 (2010).
De La Torre, R. et al. Mol. Nutr. Food Res. 58, 278–288 (2014).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuehn, B. Treating trisomies: Prenatal Down's syndrome therapies explored in mice. Nat Med 22, 6–7 (2016). https://doi.org/10.1038/nm0116-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0116-6
- Springer Nature America, Inc.
This article is cited by
-
The Role of Oxidative Stress in Trisomy 21 Phenotype
Cellular and Molecular Neurobiology (2023)
-
Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome
Scientific Reports (2017)
-
Mouse models of Down syndrome: gene content and consequences
Mammalian Genome (2016)